510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0341-2016Class II

Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic...

Leica Microsystems, Inc. / initiated 2015-09-03 / Terminated / root cause: manufacturing process

Leica Microsystems, Inc. began a recall of Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10-270 and 1mL NCL-CD10-270 are intended... on . FDA classified it as Class II and gives the reason as "These Lot numbers are not stable up to the expiry date on the product labeling". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0341-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Leica Microsystems, Inc.
Product
Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10-270 and 1mL NCL-CD10-270 are intended for the qualitative identification by light microscopy of CD10 molecules in paraffin sections.
Product code
NJT Immunohistochemistry Reagents And Kits
Reason for recall
These Lot numbers are not stable up to the expiry date on the product labeling.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Leica sent a MEDICAL DEVICE RECALL NOTIFICATION letter dated September 3, 2015 via mail to all of the consignees. The letter identified the affected, product, problem and actions to be taken. Customers are instructed to discontinue use of the reagent lots listed in the recall notification. It is requested that customers appropriately destroy any unused or partially used affected lots of the reagent, and indicate on the attached Medical Device Recall Notification Acknowledgement Form that this action has been undertaken. Customers were asked to confirm receipt of the notice as soon as possible by signing and dating the attached Medical Device Recall Notification Acknowledgement Form and fax it back to1-847-236-3747, to receive your alternative replacement for applicable orders. For questions contact your local Leica representative.
Quantity in commerce
U.S: 1 unit of CD10-270-CE-S & 66 units of CD10-270-CE. Foreign: 83 units of CD10-270-CE-S & 219 units of CD10-270-CE
Distribution
Worldwide Distribution - US Nationwide, Australia, Austria, Brazil, Canada, China, Czech Republic, Finland, France, Germany, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Netherlands, Norway, Romania, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland and UK.
Product codes and lots
CD10-270-CE-S (0.1 ml) 6033086 (U.S. Distribution) expire 06/2016, 6032390 expires 04/2016, 6033622 expires 07/2016.   CD10-270-CE (1ml) 6032742 (U.S. Distribution) expires 11/2017.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0341-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0341-2016Class IITerminatedVoluntary: Firm initiated